Approximately 3% of pregnant women take antidepressant medications. Information on the impact of antidepressants on short- and long-term maternal and offspring outcomes is highly desirable but neglected. The position that the dearth of treatment information is of greater concern than the risks to pregnant subjects involved in medical research is gaining support. Mandating the collection of reproductive outcome data in exposed childbearing women is an overdue step toward societal responsibility to our most vulnerable members.
|Original language||English (US)|
|Number of pages||4|
|Journal||Clinical pharmacology and therapeutics|
|State||Published - Oct 2009|
ASJC Scopus subject areas
- Pharmacology (medical)